Popular
- Most Recent
- Popular
- Featured
Drug combats underlying causes of Alzheimer-related dementia
A “game-changing” new drug offers both hope and time to some people diagnosed with Alzheimer’s disease, says the head of a St. Joseph’s program that played a key role in the medication’s clinical trials. Health Canada has newly approved lecanemab (brand name Leqembi, developed by Eisai Co. and...
Read more
Cyclotron hits 10,000-bombardment milestone
Cyclotron staff at St. Joseph’s Health Care London have recorded a 10,000-mark milestone in the same understated way they work every day to improve patient care and cutting-edge research. No balloons, no streamers, no fanfare: Just an efficient note atop a printout as the bombardment number spun...
Read more